Drug profile

The FDA adverse-event record for Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St

1,300 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St. See the species affected, top reactions, and outcomes below.

1,300
adverse-event reports
13.0%
death-coded share
Dog
most-reported species
449
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,300
Total Reports
169
Deaths Reported
13.0%
Death Rate

Active Ingredients

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St

Administration Routes

SubcutaneousUnknownSubconjunctivalIntramuscular

Species Affected

Dog 1,299
Cat 1

Most Affected Breeds

Retriever - Labrador 109
Terrier - Bull - American Pit 90
Chihuahua 73
Terrier - Yorkshire 68
Shih Tzu 54
Boxer (German Boxer) 54
Pug 47
Retriever - Golden 44
Dachshund (unspecified) 38
Shepherd Dog - German 33

Most Reported Reactions

Vomiting 449
Lethargy (see also Central nervous system depression in 'Neurological') 360
Facial swelling (see also 'Skin') 245
Anaphylactoid reaction 181
Diarrhoea 174
Other abnormal test result NOS 153
Anorexia 134
Pale mucous membrane 130
Hives (see also 'Skin') 121
Emesis 113
Anaphylaxis 110
Urticaria 106

Outcome Breakdown

Ongoing
600 (46.0%)
Recovered/Normal
483 (37.1%)
Died
93 (7.1%)
Euthanized
76 (5.8%)
Outcome Unknown
50 (3.8%)
Recovered with Sequela
1 (0.1%)

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St Adverse Event Insights

1,300 reports name Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St; 169 recorded a death outcome (13.0% of reported events, not a population-level mortality rate). Active ingredient: Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St. Administration routes: Subcutaneous, Unknown, Subconjunctival, Intramuscular.

By species: Dog (1,299 reports), Cat (1 reports). By breed: Retriever - Labrador (109), Terrier - Bull - American Pit (90), Chihuahua (73).

Leading clinical signs: Vomiting (449), Lethargy (see also Central nervous system depression in 'Neurological') (360), Facial swelling (see also 'Skin') (245), Anaphylactoid reaction (181). Outcome, 1,303 coded reports: Ongoing leads at 46.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.